These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9528313)

  • 1. [Estrogen receptors and the mammary gland].
    Barrón A; Bermejo L; Castro I
    Rev Invest Clin; 1997; 49(6):515-28. PubMed ID: 9528313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
    Hoffmann J; Sommer A
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse mammary tumor-like virus is associated with p53 nuclear accumulation and progesterone receptor positivity but not estrogen positivity in human female breast cancer.
    Faedo M; Ford CE; Mehta R; Blazek K; Rawlinson WD
    Clin Cancer Res; 2004 Jul; 10(13):4417-9. PubMed ID: 15240531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional regulators in mammary gland development and cancer.
    Visvader JE; Lindeman GJ
    Int J Biochem Cell Biol; 2003 Jul; 35(7):1034-51. PubMed ID: 12672473
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The estrogenic activity of synthetic progestins used in oral contraceptives enhances fatty acid synthase-dependent breast cancer cell proliferation and survival.
    Menendez JA; Oza BP; Colomer R; Lupu R
    Int J Oncol; 2005 Jun; 26(6):1507-15. PubMed ID: 15870863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cripto: a novel epidermal growth factor (EGF)-related peptide in mammary gland development and neoplasia.
    Salomon DS; Bianco C; De Santis M
    Bioessays; 1999 Jan; 21(1):61-70. PubMed ID: 10070255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential benefits of estrogens and progestogens on breast cancer.
    Schneider HP; Jackisch C
    Int J Fertil Womens Med; 1998; 43(6):278-85. PubMed ID: 9920536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
    Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
    APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A role for Id-1 in the aggressive phenotype and steroid hormone response of human breast cancer cells.
    Lin CQ; Singh J; Murata K; Itahana Y; Parrinello S; Liang SH; Gillett CE; Campisi J; Desprez PY
    Cancer Res; 2000 Mar; 60(5):1332-40. PubMed ID: 10728695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heregulin is sufficient for the promotion of tumorigenicity and metastasis of breast cancer cells in vivo.
    Atlas E; Cardillo M; Mehmi I; Zahedkargaran H; Tang C; Lupu R
    Mol Cancer Res; 2003 Jan; 1(3):165-75. PubMed ID: 12556556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormonal approach to breast cancer prevention.
    Russo IH; Russo J
    J Cell Biochem Suppl; 2000; 34():1-6. PubMed ID: 10762007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells.
    Kawai H; Li H; Chun P; Avraham S; Avraham HK
    Oncogene; 2002 Oct; 21(50):7730-9. PubMed ID: 12400015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hormonal dependence and hormonal therapy of cancers of the endometrium and breast].
    Barrat J
    Rev Fr Gynecol Obstet; 1985 Jul; 80(7):549-53. PubMed ID: 4035192
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent insight on the control of enzymes involved in estrogen formation and transformation in human breast cancer.
    Pasqualini JR; Chetrite GS
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):221-36. PubMed ID: 15860265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein kinases in mammary gland development and cancer.
    Kumar R; Wang RA
    Microsc Res Tech; 2002 Oct; 59(1):49-57. PubMed ID: 12242696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Steroid receptors and their role in the biology and control of breast cancer growth.
    Cordera F; Jordan VC
    Semin Oncol; 2006 Dec; 33(6):631-41. PubMed ID: 17145341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone mineral density in breast cancer patients with estrogen receptor-negative tumor.
    Dede DS; Dizdar O; Harputluoglu H; Altundag K
    Maturitas; 2007 Nov; 58(3):324. PubMed ID: 17945443
    [No Abstract]   [Full Text] [Related]  

  • 19. Lack of synergy between estrogen and progesterone on local IGF-I, IGFBP-3 and IGFBP-2 secretion by both hormone-dependent and hormone-independent breast cancer explants in vitro. Effect of tamoxifen and mifepristone (RU 486).
    Milewicz T; Gregoraszczuk EL; Sztefko K; Augustowska K; Krzysiek J; Ryś J
    Growth Horm IGF Res; 2005 Apr; 15(2):140-7. PubMed ID: 15809018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The NFkappaB pathway and endocrine-resistant breast cancer.
    Zhou Y; Eppenberger-Castori S; Eppenberger U; Benz CC
    Endocr Relat Cancer; 2005 Jul; 12 Suppl 1():S37-46. PubMed ID: 16113098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.